Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Trial of a Single-tablet Regimen of Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate for the Initial Treatment of Human Immunodeficiency Virus Type 2 Infection in a Resource-limited Setting: 48-Week Results From Senegal, West Africa.
Ba S, Raugi DN, Smith RA, Sall F, Faye K, Hawes SE, Sow PS, Seydi M, Gottlieb GS; University of Washington–Dakar HIV-2 Study Group. Ba S, et al. Among authors: gottlieb gs. Clin Infect Dis. 2018 Oct 30;67(10):1588-1594. doi: 10.1093/cid/ciy324. Clin Infect Dis. 2018. PMID: 29672676 Free PMC article. Clinical Trial.
In Vitro Antiviral Activity of Cabotegravir against HIV-2.
Smith RA, Wu VH, Zavala CG, Raugi DN, Ba S, Seydi M, Gottlieb GS; University of Washington-Dakar HIV-2 Study Group. Smith RA, et al. Among authors: gottlieb gs. Antimicrob Agents Chemother. 2018 Sep 24;62(10):e01299-18. doi: 10.1128/AAC.01299-18. Print 2018 Oct. Antimicrob Agents Chemother. 2018. PMID: 30012774 Free PMC article.
MK-8591 (4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine) Exhibits Potent Activity against HIV-2 Isolates and Drug-Resistant HIV-2 Mutants in Culture.
Wu VH, Smith RA, Masoum S, Raugi DN, Ba S, Seydi M, Grobler JA, Gottlieb GS; University of Washington–Dakar HIV-2 Study Group. Wu VH, et al. Among authors: gottlieb gs. Antimicrob Agents Chemother. 2017 Jul 25;61(8):e00744-17. doi: 10.1128/AAC.00744-17. Print 2017 Aug. Antimicrob Agents Chemother. 2017. PMID: 28559249 Free PMC article.
HIV Drug Resistance.
Gottlieb GS, Raugi DN, Smith RA; University of Washington-Dakar HIV-2 Study Group. Gottlieb GS, et al. N Engl J Med. 2018 Mar 1;378(9):874-5. doi: 10.1056/NEJMc1716089. N Engl J Med. 2018. PMID: 29504389 No abstract available.
Comparison of the Antiviral Activity of Bictegravir against HIV-1 and HIV-2 Isolates and Integrase Inhibitor-Resistant HIV-2 Mutants.
Smith RA, Raugi DN, Wu VH, Zavala CG, Song J, Diallo KM, Seydi M, Gottlieb GS; University of Washington-Dakar HIV-2 Study Group. Smith RA, et al. Among authors: gottlieb gs. Antimicrob Agents Chemother. 2019 Apr 25;63(5):e00014-19. doi: 10.1128/AAC.00014-19. Print 2019 May. Antimicrob Agents Chemother. 2019. PMID: 30803972 Free PMC article.
134 results